{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:49:17Z","timestamp":1791467357462,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66168-y","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:03:27Z","timestamp":1765533807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7689-0033","authenticated-orcid":false,"given":"Zhou","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-1111","authenticated-orcid":false,"given":"Yiwei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-9117","authenticated-orcid":false,"given":"Guoming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-1117","authenticated-orcid":false,"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5158-629X","authenticated-orcid":false,"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1348-6268","authenticated-orcid":false,"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"66168_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"key":"66168_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/j.gastro.2023.06.027","volume":"165","author":"KR Reddy","year":"2023","unstructured":"Reddy, K. R. et al. Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study. Gastroenterology 165, 1053\u20131063 (2023).","journal-title":"Gastroenterology"},{"key":"66168_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 20, 203\u2013222 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"66168_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat. Cancer 3, 386\u2013401 (2022).","journal-title":"Nat. Cancer"},{"key":"66168_CR5","doi-asserted-by":"crossref","unstructured":"Arab, Z.N. et al. Phytochemicals as modulators of paraoxonase-1 in health and diseases. Antioxidants 11, 1273 (2022).","DOI":"10.3390\/antiox11071273"},{"key":"66168_CR6","doi-asserted-by":"crossref","unstructured":"Castane, H. et al. Serum arylesterase, paraoxonase, and lactonase activities and paraoxonase-1 concentrations in morbidly obese patients and their relationship with non-alcoholic steatohepatitis. Antioxidants 12, 2038 (2023).","DOI":"10.3390\/antiox12122038"},{"key":"66168_CR7","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.1002\/fsn3.3713","volume":"11","author":"MY Zamanian","year":"2023","unstructured":"Zamanian, M. Y. et al. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non-alcoholic fatty liver disease: Focus on oxidative stress and inflammation. Food Sci. Nutr. 11, 7485\u20137503 (2023).","journal-title":"Food Sci. Nutr."},{"key":"66168_CR8","doi-asserted-by":"publisher","first-page":"e1801001","DOI":"10.1002\/mnfr.201801001","volume":"63","author":"D Leclerc","year":"2019","unstructured":"Leclerc, D. et al. Mild methylenetetrahydrofolate reductase deficiency alters inflammatory and lipid pathways in liver. Mol. Nutr. Food Res. 63, e1801001 (2019).","journal-title":"Mol. Nutr. Food Res."},{"key":"66168_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep4.1438","volume":"3","author":"JS Maras","year":"2019","unstructured":"Maras, J. S. et al. Dysregulated lipid transport proteins correlate with pathogenesis and outcome in severe alcoholic hepatitis. Hepatol. Commun. 3, 1598\u20131625 (2019).","journal-title":"Hepatol. Commun."},{"key":"66168_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/liv.12308","volume":"34","author":"S Desai","year":"2014","unstructured":"Desai, S. et al. Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis. Liver Int 34, 110\u20137 (2014).","journal-title":"Liver Int"},{"key":"66168_CR11","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3390\/ijms20164049","volume":"20","author":"MJ Meneses","year":"2019","unstructured":"Meneses, M. J. et al. Paraoxonase-1 as a regulator of glucose and lipid homeostasis: impact on the onset and progression of metabolic disorders. Int. J. Mol. Sci. 20, 4049 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"66168_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcancer.2017.11.013","volume":"56","author":"T Bacchetti","year":"2019","unstructured":"Bacchetti, T., Ferretti, G. & Sahebkar, A. The role of paraoxonase in cancer. Semin. Cancer Biol. 56, 72\u201386 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"66168_CR13","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1021\/pr3011815","volume":"12","author":"C Huang","year":"2013","unstructured":"Huang, C. et al. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. J. Proteome Res 12, 1838\u201346 (2013).","journal-title":"J. Proteome Res"},{"key":"66168_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.21037\/atm.2020.01.44","volume":"8","author":"GY Ding","year":"2020","unstructured":"Ding, G. Y. et al. Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma. Ann. Transl. Med. 8, 204 (2020).","journal-title":"Ann. Transl. Med."},{"key":"66168_CR15","doi-asserted-by":"publisher","first-page":"1104262","DOI":"10.3389\/fonc.2023.1104262","volume":"13","author":"C Han","year":"2023","unstructured":"Han, C. et al. Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma. Front. Oncol. 13, 1104262 (2023).","journal-title":"Front. Oncol."},{"key":"66168_CR16","doi-asserted-by":"crossref","unstructured":"Dong, L. et al. Transcriptomic analysis of Paraoxonase 1 expression in hepatocellular carcinoma and its potential impact on tumor immunity. Clin. Transl. Oncol. 27, 612\u2013629 (2024).","DOI":"10.1007\/s12094-024-03598-y"},{"key":"66168_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151\u2013172 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"66168_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2024.01.011","volume":"80","author":"P Tabrizian","year":"2024","unstructured":"Tabrizian, P., Abdelrahim, M. & Schwartz, M. Immunotherapy and transplantation for hepatocellular carcinoma. J. Hepatol. 80, 822\u2013825 (2024).","journal-title":"J. Hepatol."},{"key":"66168_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78, 770\u2013782 (2023).","journal-title":"J. Hepatol."},{"key":"66168_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s43018-023-00672-2","volume":"5","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy. Nat. Cancer 5, 167\u2013186 (2024).","journal-title":"Nat. Cancer"},{"key":"66168_CR21","doi-asserted-by":"publisher","first-page":"e2302910","DOI":"10.1002\/advs.202302910","volume":"10","author":"X Cao","year":"2023","unstructured":"Cao, X. et al. Oral immunotherapy reshapes intestinal immunosuppression via metabolic reprogramming to enhance systemic anti-tumor immunity. Adv. Sci. 10, e2302910 (2023).","journal-title":"Adv. Sci."},{"key":"66168_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41423-018-0001-7","volume":"15","author":"E Mohamed","year":"2018","unstructured":"Mohamed, E., Al-Khami, A. A. & Rodriguez, P. C. The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates. Cell Mol. Immunol. 15, 421\u2013427 (2018).","journal-title":"Cell Mol. Immunol."},{"key":"66168_CR23","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/1078-0432.CCR-22-3350","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar, K. et al. Reversal of lactate and PD-1\u2013mediated macrophage immunosuppression controls growth of PTEN\/p53-deficient prostate cancer. Clin. Cancer Res. 29, 1952\u20131968 (2023).","journal-title":"Clin. Cancer Res."},{"key":"66168_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","volume":"77","author":"JY Wu","year":"2020","unstructured":"Wu, J. Y. et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol. Cell 77, 213\u2013227 (2020).","journal-title":"Mol. Cell"},{"key":"66168_CR25","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/0008-5472.CAN-19-1059","volume":"79","author":"S Shang","year":"2019","unstructured":"Shang, S. et al. Macrophage ABHD5 suppresses NFkappaB-dependent matrix metalloproteinase expression and cancer metastasis. Cancer Res. 79, 5513\u20135526 (2019).","journal-title":"Cancer Res."},{"key":"66168_CR26","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.cmet.2024.04.019","volume":"36","author":"JL Liu","year":"2024","unstructured":"Liu, J. L. et al. Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells. Cell Metab. 36, 1320\u20131334 (2024).","journal-title":"Cell Metab."},{"key":"66168_CR27","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2022.04.017","volume":"55","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. Immunity 55, 1067\u20131081 (2022).","journal-title":"Immunity"},{"key":"66168_CR28","doi-asserted-by":"crossref","unstructured":"Wang, Z., et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J. Immunother. Cancer 9, 2787 (2021).","DOI":"10.1136\/jitc-2021-002787"},{"key":"66168_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","volume":"15","author":"Y Yan","year":"2022","unstructured":"Yan, Y. et al. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. J. Hematol. Oncol. 15, 104 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"66168_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"66168_CR31","doi-asserted-by":"crossref","unstructured":"Zhou, J., et al. Lactate supports Treg function and immune balance via MGAT1 effects on N-glycosylation in the mitochondria. J. Clin. Invest. 134, e175897 (2024).","DOI":"10.1172\/JCI175897"},{"key":"66168_CR32","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen, X. & Calvisi, D. F. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am. J. Pathol. 184, 912\u2013923 (2014).","journal-title":"Am. J. Pathol."},{"key":"66168_CR33","doi-asserted-by":"publisher","first-page":"110986","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells. Cell Rep. 39, 110986 (2022).","journal-title":"Cell Rep."},{"key":"66168_CR34","doi-asserted-by":"crossref","unstructured":"Tan, S.N. et al. Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39. J. Exp. Med. 222, e20240445 (2025).","DOI":"10.1084\/jem.20240445"},{"key":"66168_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u20135 (1999).","journal-title":"Nature"},{"key":"66168_CR36","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1128\/MCB.24.12.5209-5222.2004","volume":"24","author":"C Gouedard","year":"2004","unstructured":"Gouedard, C., Barouki, R. & Morel, Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell Biol. 24, 5209\u201322 (2004).","journal-title":"Mol. Cell Biol."},{"key":"66168_CR37","doi-asserted-by":"crossref","unstructured":"Wang, Y., et al. Quercetin regulates lipid metabolism and fat accumulation by regulating inflammatory responses and glycometabolism pathways: a review. Nutrients 16, 1102 (2024).","DOI":"10.3390\/nu16081102"},{"key":"66168_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bcp.2010.11.008","volume":"81","author":"LG Costa","year":"2011","unstructured":"Costa, L. G., Giordano, G. & Furlong, C. E. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem. Pharm. 81, 337\u201344 (2011).","journal-title":"Biochem. Pharm."},{"key":"66168_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2017.06.002","volume":"48","author":"D Martini","year":"2017","unstructured":"Martini, D. et al. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression. J. Nutri. Biochem. 48, 1\u20138 (2017).","journal-title":"J. Nutri. Biochem."},{"key":"66168_CR40","doi-asserted-by":"publisher","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","volume":"590","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett. 590, 216837 (2024).","journal-title":"Cancer Lett."},{"key":"66168_CR41","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1021\/pr400050u","volume":"12","author":"A Garcia-Heredia","year":"2013","unstructured":"Garcia-Heredia, A. et al. Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach. J. Proteome Res. 12, 1946\u201355 (2013).","journal-title":"J. Proteome Res."},{"key":"66168_CR42","doi-asserted-by":"crossref","unstructured":"Meneses, M.J. et al. Paraoxonase-1 as a regulator of glucose and lipid homeostasis: impact on the onset and progression of metabolic disorders. Int. J. Mol. Sci. 20, 4049 (2019).","DOI":"10.3390\/ijms20164049"},{"key":"66168_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/biof.1549","volume":"46","author":"J Kotur-Stevuljevic","year":"2020","unstructured":"Kotur-Stevuljevic, J. et al. Paraoxonase 1 and atherosclerosis-related diseases. Biofactors 46, 193\u2013205 (2020).","journal-title":"Biofactors"},{"key":"66168_CR44","doi-asserted-by":"publisher","first-page":"108067","DOI":"10.1016\/j.diabres.2020.108067","volume":"161","author":"Y Shokri","year":"2020","unstructured":"Shokri, Y. et al. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: genotypic and phenotypic evaluation. Diab. Res. Clin. Pr. 161, 108067 (2020).","journal-title":"Diab. Res. Clin. Pr."},{"key":"66168_CR45","doi-asserted-by":"crossref","unstructured":"Aldonza, M.B.D. et al. Multi-targeted therapy resistance via drug-induced secretome fucosylation. Elife 12, e75191 (2023).","DOI":"10.7554\/eLife.75191"},{"key":"66168_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1074\/mcp.M113.028621","volume":"13","author":"JM Ahn","year":"2014","unstructured":"Ahn, J. M. et al. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol. Cell Proteom. 13, 30\u201348 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"66168_CR47","first-page":"163","volume":"23","author":"H Shu","year":"2017","unstructured":"Shu, H. et al. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1. Discov. Med 23, 163\u2013168 (2017).","journal-title":"Discov. Med"},{"key":"66168_CR48","doi-asserted-by":"crossref","unstructured":"Wu, H., et al. Quercetin inhibits the proliferation of glycolysis-addicted HCC cells by reducing hexokinase 2 and Akt-mTOR pathway. Molecules 24, 1993 (2019).","DOI":"10.3390\/molecules24101993"},{"key":"66168_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/hep.32442","volume":"77","author":"Z Lu","year":"2023","unstructured":"Lu, Z. et al. Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma. Hepatology 77, 745\u2013759 (2023).","journal-title":"Hepatology"},{"key":"66168_CR50","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1053\/j.gastro.2019.01.250","volume":"156","author":"Y Wei","year":"2019","unstructured":"Wei, Y. et al. Plasma cell polarization to the immunoglobulin G phenotype in hepatocellular carcinomas involves epigenetic alterations and promotes hepatoma progression in mice. Gastroenterology 156, 1890\u20131904 (2019).","journal-title":"Gastroenterology"},{"key":"66168_CR51","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-025-57603-1","volume":"16","author":"Z Wen","year":"2025","unstructured":"Wen, Z. et al. Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice. Nat. Commun. 16, 2362 (2025).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66168-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:03:33Z","timestamp":1765533813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66168-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66168"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66168-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11034"}}